Convalescent Plasma Decision May Be ‘Week Or Two’ Away, US FDA’s Hahn Says

 
• By Derrick Gingery
  
Coronavirus 2019-nCoV Blood Sample. Corona virus outbreaking. Epidemic virus Respiratory Syndrome. China
FDA Commissioner Stephen Hahn expects convalescent plasma data to inform coronavirus monoclonal antibody and vaccine research. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet